Hasan Ashraf, MD
Clinical Cardiac Electrophysiology · Temple, TXNPI 1205217361
Payments from drug & device makers
Across 29 payments — averaging $134.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abbott$888
- Biosense Webster, Inc.$146
- Abiomed$105
- Boston Scientific$92
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$79
- plus $77 from 3 others
What the payments were for
- Grants$1,00026%
- Travel & lodging$1,01326%
- Food & beverage$81921%
- Education$1,07528%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 13 | $2,519 |
| Abbott | 6 | $888 |
| Biosense Webster, Inc. | 1 | $146 |
| Abiomed | 1 | $105 |
| Boston Scientific | 2 | $92 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $79 |
| W. L. Gore & Associates, Inc. | 3 | $48 |
| Cardiva Medical, Inc. | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,907 in reported general payments places this provider in the 5th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 167 | $117,482 |
| EntrestoSacubitril/Valsartan | 54 | $33,414 |
| Mexiletine Hcl | 36 | $2,255 |
| SotalolSotalol Hcl | 102 | $1,579 |
| Amiodarone Hcl | 92 | $1,386 |
| Metoprolol Succinate | 117 | $1,327 |
| Losartan Potassium | 60 | $561 |
| Cephalexin | 64 | $514 |
| Flecainide Acetate | 18 | $459 |
| Carvedilol | 80 | $378 |
| Lisinopril | 31 | $213 |
| Amlodipine Besylate | 15 | $145 |
| Metoprolol Tartrate | 49 | $131 |
| ClopidogrelClopidogrel Bisulfate | 12 | $107 |
| Pantoprazole Sodium | 24 | $99 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Temple
- Javier BanchsTemple$148K
- Andrea NataleAustin$7.8M
- George ManoukianShenandoah$3.2M
- Rodney HortonAustin$2.5M
- Stanislav WeinerLongview$2.4M
- Michael DelaughterBedford$2.1M
- James DevillePlano$1.5M
- Robert CanbyAustin$1.5M
- Amin Al-AhmadAustin$1.4M
- Theodore TakataFort Worth$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.